Evidence map›Paper›PMID 36507163›Full record

ArticleChemical science2022

A robust hollow metal-organic framework with enhanced diffusion for size selective catalysis.

Chunhui Wu, Xiaowen Zhao, Dongxu Wang, Xiaomeng Si, Tao Li

Abstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chunhui WuSchool of Physical Science and Technology, ShanghaiTech University Shanghai 201210 People's Republic of China litao1@shanghaitech.edu.cn.ORCID https://orcid.org/0000-0002-6108-7002
Xiaowen ZhaoSchool of Physical Science and Technology, ShanghaiTech University Shanghai 201210 People's Republic of China litao1@shanghaitech.edu.cn.ORCID https://orcid.org/0000-0002-8903-1297
Dongxu WangSchool of Physical Science and Technology, ShanghaiTech University Shanghai 201210 People's Republic of China litao1@shanghaitech.edu.cn.
Xiaomeng SiSchool of Physical Science and Technology, ShanghaiTech University Shanghai 201210 People's Republic of China litao1@shanghaitech.edu.cn.ORCID https://orcid.org/0000-0002-3046-4047
Tao LiSchool of Physical Science and Technology, ShanghaiTech University Shanghai 201210 People's Republic of China litao1@shanghaitech.edu.cn.ORCID https://orcid.org/0000-0001-7586-9841

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single crystalline (SC) hollow metal-organic frameworks (MOFs) are excellent host materials for molecular and nanoparticle catalysts. However, due to synthetic challenges, chemically robust SC hollow MOFs are rare. This work reports the construction of a defect-free and chemically stable SC hollow MOF, MOF-801(h), through templated growth from a unit cell mismatched core, UiO-66. Under the protection of excess MOF-801 ligand, fumaric acid, the MOF-801 shell was perfectly retained while the isoreticular UiO-66 core was selectively and completely etched away by formic acid. The combination of a large cavity, small aperture and short diffusion length allows the Pt nanoparticle encapsulated composite catalyst, Pt⊂MOF-801(h), to perform size selective hydrogenation of nitro compounds at an accelerated speed. Impressively, the catalyst can undergo concentrated HCl or boiling water treatment while maintaining its crystallinity, morphology, catalytic activity, and size selectivity. In addition, Au nanoparticles encapsulated catalyst, Au⊂MOF-801(h), was used for the size selective nucleophilic addition of HCl to terminal alkynes for the first time, which is a harsh reaction involving high concentrations of a strong acid.

Identifiers

PMID36507163
PMCPMC9682891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.